The mixed results are a blow for bepranemab and for related antibodies that target a mid-region epitope on tau. But exploratory analyses of the results hint at a path forward for these candidates.

The company aims to supercharge antibody treatments using specially designed protein “cages” that multiply their effects, opening up new opportunities in drug development. The company was spun ...

Ueda is holding an expandable toy that he uses to demonstrate how the company’s computationally designed Antibody Cages work. (GeekWire Photo / Alan Boyle) Three weeks after University of ...

Therapeutic antibodies are an important alternative option, but resistance has developed owing to the emergence of viral variants. A new paper in Cell reports the development of an antibody with ...

ISLAMABAD: The Islamabad High Court (IHC) set aside the Medical and Dental College Admission Test (MDCAT) 2024 results and ordered to reconduct it, ARY News reported. In its order, the IHC ...

ISLAMABAD: Two ben­c­hes of the Islamabad High Court (IHC) issued contrasting rulings on identical cases concerning access to imprisoned former prime minister Imran Khan. IHC Chief Justice Aamer ...

Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 465-8603, Japan Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural ...

ISLAMABAD: The Islamabad High Court (IHC) on Thursday ordered the Adiala jail superintendent to present Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan, who is behind bars, before the court ...

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

About clesrovimab (MK-1654) Clesrovimab (MK-1654) is an investigational, extended half-life monoclonal antibody (mAb) developed as a passive immunization for the prevention of RSV. Clesrovimab is ...